JPRN-UMIN000027422已完成未知
Effects of Dapagliflozin on Stabilizing Coronary Atherosclerotic Plaques: Using IB-IVUS Imaging Study - Effects of Dapagliflozin on Stabilizing Coronary Atherosclerotic Plaques: Using IB-IVUS Imaging Study
Division of Cardiology, Nagoya Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2017年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with severe ketosis, diabetic coma or precoma 2)Patients with severe infection, perioperative, a severe trauma 3)Patients with moderate renal dysfunction (eGFR: less than 45 ml/min/1.73m2) 4)Patients with severe hepatic dysfunction 5)Patients who are treated with insulin 6)Patients who need treatment with pioglitazone 7)Patients who need treatment with GLP-1RA 8)Patients with a history of hypersensitivity to SGLT-2 inhibitors 9)Women who are or may be pregnant 10)Patients who are treated with PCSK-9 inhibitor 11)Patients who have been determined to be unsuitable for the attending physician
研究者
相似试验
招募中
1 期
DTYPE 2 DIABETESMedDRA version: 20.0Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2016-003614-27-ITIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI52
尚未招募
2 期
Dapagliflozin in Pulmonary Arterial HypertensioPulmonary arterial hypertension.Primary pulmonary hypertensionI27. 0IRCT20200209046427N2Shahid Beheshti University of Medical Sciences100
终止
不适用
Effects of dapaglifloziN Therapy on myocardial perfusion Reserve in prediabetic patients with stable coronarY artery diseaseKCT0004802Asan Medical Center60
已完成
3 期
DECLARE-TIMI58JPRN-jRCT2080222423AstraZeneca KK17,150
已完成
3 期
Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by CardiotomographyDiabete Type 2Myocardial InfarctionUnstable AnginaDiabetes Mellitus, Type 2NCT05998525Hilda Elizabeth Macías Cervantes54